BEAPHAR FLEA COLLAR FOR CATS

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)

Commercializzato da:

Beaphar B.V.

Codice ATC:

QP53AF03

INN (Nome Internazionale):

DIMPYLATE (AS STABILIZED DIAZINON AT 92% DIAZINON)

Dosaggio:

2.1 Grams

Forma farmaceutica:

Collar

Tipo di ricetta:

CAM-Companion Animal Medicine

Gruppo terapeutico:

Feline

Area terapeutica:

Dimpylate

Indicazioni terapeutiche:

Ectoparasiticide

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2012-06-15

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar Flea Collar for Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ONE COLLAR OF 35 CM LENGTH (14 G) CONTAINS:
ACTIVE SUBSTANCE:
Dimpylate (as stabilized diazinon at 92% diazinon) 2.1 g
EXCIPIENTS:
Erythrosine (E127)
0.042 g
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Collar
Red, PVC collar.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of cats infested with fleas (_Ctenocephalides felis_)
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance, or to any of the excipients.
Do not use on sick and recovering cats.
Do not use in known cases of liver disorder.
Do not use on pregnant animals.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
When fitting, ensure that the collar is not too tight. Loosen the collar as the cat grows bigger.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 22/11/2016_
_CRN 7024441_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Due to the potential risk of hypersensitivity developing in humans to dimpylate, unnecessary handling of this product
should be avoided.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
An intoxification typical for organophosphorus compounds occurs rarely. Rarely, local skin reaction at the site of collar
application may occur. Such reactions may be associated with either skin sensitivity to some of the substances in the collar
or an incorrectly fitted collar (too tight). If local skin